The authors regret to inform that we recently discovered an error in this article. One of the exosomal miRNAs that was detected in all patient samples, miR-29a-3p, was in the article erroneously labeled and described as being significantly differently expressed between two patient groups (TRG 1 *versus* TRG 2-3) within the investigation and validation cohorts. Fortunately, miR-29a-3p had not been selected for down-stream analyses, averting consequential errors within the study.

Below follows a list of edits pertaining to the correct labeling of *[miR-29a-3p as not being differently expressed between the patient groups TRG 1 and TRG 2-3 in the investigation and validation cohorts]{.ul}*. The edits are **[in bold and underlined]{.ul}**.

We sincerely regret if our inadvertent mistake has caused confusions. The conclusions drawn from the experiments are not affected.

1\. ***Results, the first and second paragraphs***, should read:

Of the initial 372 exosomal miRNAs tested in the investigation cohort, 44 were detected in all samples, with an average of 135 miRNAs per sample (Supplementary Table 2 and Supplementary Table 3A). Analysis with SAM uncovered 37 miRNAs with significantly altered expression according to N- or M-status, or TRG (Supplementary Table 1). Of these, **[five]{.ul}** miRNAs with a strong probability of relation to M-status and TRG were verified using single parameter Student\'s *t* test (Supplementary Table 1).

The observed significant associations presented in Figure 1 show that **[there was no difference in]{.ul}** expression of miR-29a-3p **[between TRG groups]{.ul}**, and low levels of miR-301a-3p were found in patients with poor tumor response (TRG 2-3) to neoadjuvant therapy in the investigation cohort. Further, miR-141-3p, miR-375, miR-423-5p, and miR-431-3p were all found to be higher expressed in patients with synchronous liver metastasis. **[The top]{.ul}** six miRNAs were selected for validation along with seven miRNAs as reference for normalization.

2\. The corrected ***Figure 1*** is shown below, where **[the erroneous asterisks in panel E have been removed]{.ul}**. This does not affect the figure legend, which reads as in the published article version.Image 1

3\. ***Supplementary Table 1*** miRNA selection overview. In the investigation cohort, 36 miRNAs had significantly altered expression according to node (N) or metastatic (M)-status, or tumor regression grade (TRG) noted as fold change between the groups in the Significance Analysis of Microarrays (SAM) software. Of these 36, **[five]{.ul}** were verified using single parameter Student\'s *t* test. We selected **[the top]{.ul}** six for validation, and added another 7 miRNAs with the highest stability to validate in the independent validation cohort.STEPFirstSecondThirdAll miRNA associated with clinical endpoints according to SAMResults from SAM controlled in single parameter Student\'s *t* testResults from Investigation cohort validated in larger independent cohortInvestigation cohortValidation cohortmiRNA*n*TNMTRGypTypNP-value (Student\'s *t* test)*n*P-value (Student\'s *t* test)**All miRNA highlighted by SAMSelected for further validationhsa-miR-141-3p**200.7710.01064\<0.000**hsa-miR-375**240.6460.01763\<0.000**hsa-miR-301a-3p**211.3000.024640.593**hsa-miR-423-5p**29-1.2730.008640.160**hsa-miR-431-5p**200.8000.005610.646**hsa-miR-29a-3p**290.935**[0.730]{.ul}**64**[0.725]{.ul}**hsa-miR-1181.1430.118hsa-miR-128-3p281.1600.087hsa-miR-135a-5p80.573NAhsa-miR-138-5p41.320NAhsa-miR-186-5p171.1500.063hsa-miR-193a-3p81.603NAhsa-miR-204-5p80.570NAhsa-miR-206101.3650.139hsa-miR-29b-2-5p71.324NAhsa-miR-323a-3p81.402NAhsa-miR-335-5p251.2140.024hsa-miR-337-5p150.8060.190hsa-miR-33a-5p271.2500.104hsa-miR-34670.602NAhsa-miR-34c-5p130.616NAhsa-miR-369-5p31.415NAhsa-miR-382-5p231.2190.158hsa-miR-410-3p190.8200.079hsa-miR-449a131.5380.973hsa-miR-450a-5p110.574NAhsa-miR-491-5p71.564NAhsa-miR-545-3p130.602NAhsa-miR-551b-3p170.8270.499hsa-miR-570-3p31.333NAhsa-miR-576-5p121.3560.679hsa-miR-76561.362NAhsa-miR-92a-3p291.2440.178hsa-miR-940140.5791.266NA/0.206hsa-miR-98-5p221.1130.159SNORD49A81.419NA

The authors would like to apologise for any inconvenience caused.
